FIELD: medicine.
SUBSTANCE: patient's blood serum is examined for the initial alveomucine content. If the value is within the range to 45.0 Units/ml enables predicting a low risk of developing respiratory insufficiency; if the present level is exceeded, and the value gains in progression, a high risk of developing respiratory insufficiency in progression is predicted.
EFFECT: use of the invention enables short-term prediction of a risk of developing respiratory insufficiency in the patients suffering hemorrhagic fever and renal syndrome.
1 tbl, 2 ex
Authors
Dates
2012-09-20—Published
2011-03-11—Filed